| Question |
 |
|
| Answer |
|
|
| Acetaminopen/Codeine |
Class: Narcotics/NSAID Combo... Indication: Pain, cough |
| Albuterol |
Class: Beta-2 adrenergic agonist Indication: bronchospasms |
| Alendronate |
Class: Osteoporosis/Calcium Metabolism MofA: inhibits osteoclast activity (bisphosphate) Indication: Osteoporosis, Pagets disease |
| Allopurinol |
Class: Nephrolithiasis ; Gout MofA: inhibits xanthine oxidase, dec Uric acid Indication: Gout prophylaxis, hyperuricemia |
| Amlodipine |
Class: Calcium Channel Blocker, dihydropyridines Indication: HTN, CAD |
| Amlodipine+Benazepril |
Class: Calcium Channel Blocker+ACE inhib Indication: HTN |
| Amphetamine+Dextroamphetamine |
Class: Stimulants MofA: stimulates CNS, blocks reuptake of NE & Dopa Indication: ADHD |
| Atomoxetine |
Class: psychotropic agent/antidepressant MofA: inhib pre-synaptic NE transport Indication: ADHD |
| Atorvastin |
Class: Cholesterol Lowering Mofa: inhibs HmgCoA "statin" Indication: Hyperlipidermia/Hypercholesterolemia |
| Bupropion |
Class: Antidepressants, other MofA: unknown, but known blocks NE/Dopa reuptake Indication: Depression, Seasonal Affective Disorder, ADHD |
| Rabeprazole |
Class: Antacid Mofa: PPI Indication: GERD, PUP, Zollinger-Elison Syndrome |
| Esomeprazole |
Class: Antacid MofA: PPI Indication: GERD, PUP, Zollinger-Elison Syndrome |
| Lansoprazole |
Class: Antacid MofA: PPI Indication: GERD, PUP, Zollinger-Elison |
| Pantoprazole |
Class: Antacid MofA: PPI Indication: GERD, PUP, Zollinger-Elison |
| Polyethylene Glycol |
Class: Osmotic Laxative MofA: H2O retention in stool Indicatio: Constipation |
| Pioglitazone |
Class: Diabetes Med MofA: Increases Insulin Sensitivity |
| Rosiglitazone |
Class: Diabetes Med MofA: Increases Insulin Sensitivity |
| Insulin Lispro |
Class: Diabetes Med MofA: stimulates peripheral glucose uptake, inhibs hepatic glucose prod, inhibits lipolysis & proteolysis Indication: DM and hyperglycemia |
| Insulin glargine |
Class: Diabetes Med MofA: stimulates peripheral glucose uptake, inhibs hepatic glucose prod, inhibits lipolysis & proteolysis Indication: DM and hyperglycemia |
| Metformin |
Class: Diabetes meds Mofa: dec hepatic glucose prod & and intestinal absorption |
| Levothyroxine |
Class: Thyroid med MofA: analogue to thyroxine (multiple effects) Indication: Hypothyroid |
| Latanoprost |
Class: Glaucoma med MofA: Prostaglandin F-alpha-2 analogue...increases vitreous outflow Indication: IOP |
| Warfarin |
Class: Anti-coag MofA: Inhibs Vit K coag Factor syn (II, VII, IX, X, Protein and S) Indication: DVT |
| Clopidrogel |
Class: Anticoag MofA: inhibits ADP binding to platelet receptor Indication: Thrombotic event risk |
| Moxifloxacin |
Class: Antimicrobial MofA: Fluoroquinolone (inhibs DNA gyrase) |
| Levofloxacin |
Class: Antimicrobial MofA: Fluoroquinolone (inhibs DNA gyrase) |
| Cefdinir |
Class: Antimicrobial MofA: 3rd gen Cephalo...Beta lactamIndication: broad spectrum |
| Valacyclovir |
Class: Antimicrobial MofA: inhibs viral DNA synthesis Indication: HSV infection |
| Methylphenidate |
Class: PsychotropicMofA: stimulates CNS, blocks reuptake of NE & Dopa Indication: ADHD |
| Zolpidem |
Class: Sedatives MofA: GABA-Benzodiazepine recep interaction Indication: Insomnia |
| Eszopiclone |
Class: Sedatives MofA: GABA-Benzodiazepine recep interaction Indication: Insomnia |
| Donepezil |
Class: Dementia Drug MofA: inhibits Acytelcholinesterase Indication mild/severe Azheimers |
| Memantine |
Class Dementia Drug MofA: NMDA receptor Antag...slow Ca++ influx Indication: Alzheimers, mod/severe dementia |
| Ropinirole |
Class: Parkinsons drug MOFA: Dopamine agonist Indication: Parkinsons, Restless Leg |
| Duloxetine |
Class: Antidepressant MofA: SSRI Indication: Major Depressive Disorder |
| Venlafaxine |
Class: Antidepressant MofA: SSRI, NE, Dopa reuptake inhibitor Indication: Major Depressive Disorder, Panic Disorder, Generalized Anxiety Disorder, Social Anxiety disorder |
| Escitalopram |
Class: Antidepressant MofA: SSRI Indication: Major Depressive Disorder, Generalized Anxiety |
| Trazadone |
Class: Antidepressant MofA: SSRI Indication: Major depression, Anxiety, Insomnia |
| Escitalopram |
Class: Antidepressant MofA: SSRI Indication: Major depression, Anxiety, Insomnia |
| Lorazepam |
Class: Anticonvulsant/Sedative MofA: Binds Benzodiazepine receptors to enhance GABA Indication: insomnia, nause vomiting (chemo related), status epilepticus |
| Pregabalin |
Class: analgesic MofA: Gaba analogue, inc levels of Gaba Indication: Anxiety, Neuralgia |
| Olanzapine |
Class: Antipsychotic MofA: antagonizes D2 receptor, 5HT2 receptor and others Indication: Mania, Schizophrenia |
| Risperidone |
Class: Antipsychotic MofA: antagonizes D2 receptor, 5HT2 receptor and others Indication: Mania, Schizophrenia |
| Quetiapine |
Class: Antipsychotic MofA: antagonizes D2 receptor, 5HT2 receptor and others Indication: Mania, Schizophrenia |
| Topiramate |
Class: Anticonvulsant/Migraine med MofA: unknown Indication: seizures, migraines |
| Clonazepam |
Class: Anticonvulsant/Sedative MofA: Binds Benzodiazepine receptors to enhance GABA Indication: insomnia, nause vomiting (chemo related), status epilepticus |
| Divalproex Sodium |
Class: Anticonvulsant/Migraine med MofA: unknown/ Na Channel blocker Indication: Seizures, migraines |
| Lamotrigine |
Class: Anticonvulsant/Migraine med MofA: unknown/ Na Channel blocker Indication: absence/partial/tonic-clonic seizures |
| Vernicline |
Class: Smoking cessation MofA: antagonizes AcH nicotinic receptors Indication: smoking |
| Celecoxib |
Class: Pain Reliever/NSAID MofA: Cox-2 inhib Inidication: Osteoarthritis, RA, Dysmenorrhea |
| Oxycodone+acetominophen |
Class: Pain reliever MofA: Opiod receptor binding + NSAID Indication: Mod-severe pain |
| Hydrocodone + Acetaminophen |
Class: Pain reliever MofA: Opiod receptor binding + NSAID Indication: Mod-severe pain |
| Lidocaine Patch |
Class: analgesic/anasthetic MofA: inhibs Na channel, stabilizes neuronal member Indication: post-herpetic neuralgia |
| Naproxen |
lass: Pain Reliever/NSAID MofA: Cox inhib Inidication: Osteoarthritis, RA, Dysmenorrhea |
| Sumatriptan |
Class: SSRI/Migraine Med MofA: Activates vascular 5HT1 receptors Indication: Migraines , cluster HAs |
| Metaxalone |
Class: muscle relaxant MofA: centrally acting Indication: muscle spasm |
| Cyclobenzaprine |
Class: muscle relaxant MofA: centrally acting Indication: muscle spasm |
| Furosemide |
Class: Hypertensive med MofA: inhibs loop of henle and PCT resorption Indication: HTN, Pulmonary Edema, Hypercalcemia |
| HCTZ |
Class: Hypertensive MofA: diuretic, inhibs NA and CL resorption at DCT Indication: edema, HTN |
| Rampiril |
Class: Hypertensive MofA: ACE inhibitor Indicaton: HTN, CHF, Cardiac event risk |
| Losartan |
Class: Hypertensive MofA: A2RB Indication: HTN, neuropathy |
| Irbesartan |
Class: Hypertensive MofA: A2RB Indication: HTN, neuropathy |
| Olmesartan + HCTZ |
Class: Hypertensive MofA: A2RB+ DCT diuretic Indication: HTN, neuropathy |
| Valsartan + HCTZ |
Class: Hypertensive MofA: A2RB+ DCT diuretic Indication: HTN, neuropathy |
| Triamterene + HCTZ |
Class: Hypertensive MofA: inhibs Aldosterone-induced sodium resorption+ inhibs Na+Cl resorption @ DCT Indication: HTN |
| Amlodipine |
Class: Hypertensive MofA: Calcium Channel Blocker Indication: HTN, CAD |
| Amlodipine + Benazepril |
Class: Hypertensive MofA: Calcium Channel Blocker+ ACE inhibitor Indication: HTN, CAD |
| Carvedilol |
Class: Beta blocker MofA: antagonizes Beta1 and Beta2 receps (and Alpha1) Indication: CHF, HTN, Liver dysfunction, Post MI |
| Metroprolol |
Class: Beta Blocker MofA: antagonizes Beta 1 and Beta 2 Indication: CHF, HTN, Angina |
| Digoxin |
Class: Antiarhythmic MofA: inhibs Na/K pump Indication: CHF, Vtach |
| Rosuvastatin |
Class: Cholesterol lowering MofA: inhibs HMG-CoA reductase Indication: Hyperlipidemia, Hypercholesterolemia |
| Atorvastatin |
Class: Cholesterol lowering MofA: inhibs HMG-CoA reductase Indication: Hyperlipidemia, Hypercholesterolemia |
| Niacin |
Class: Cholesterol Lowering MofA: participates in respiration Ox-Red, dec LDL and VDL Indication: hypercholesteralemia, dyslipidemia |
| Fenofibrate |
Class: Cholesterol lowering MofA: inhibs triglyceride synthesis Indication: dyslipidemia |
| Ezetimibe + Simvastatin |
Class: Cholesterol Lowering MofA: Inhibs chol uptake at brush border + inhibs HMG CoA reductase Indicatin: familial hypercholesteralemia |
| Ezetimibe |
Class: Cholesterol lowering MofA: inhibs chol uptake at brush border |
| Potassium |
Indication: hypokalemia |
| Albuterol |
Class: Bronchodilator MofA: Beta-2 agonist Indication: bronchospasms |
| Salmeterol + Fluticasone |
Class: Bronchodilator MofA: Beta-2 agonist+ Antihistamine Indication: bronchospasms, asthma |
| Ipratropium + Albterol |
Class: Bronchodilator MofA: Blocks AcH at receptor+Beta-2 Agonist Indication: bronchospasm |
| Tiotropium |
Class: Bronchodilator Mofa: antagonizes M1, M2, M3 AcH receptrors Indication: COPD |
| Motelukast |
CLass: Antiinflamm Mofa: binds leukotriene receps Indication: Asthma maintenance, allergic rhinitis |
| Fexofenadine |
Class: Allergy med MofA: antihistamine (H1) Indication: allergic rhinitis |
| Fluticasone |
Class: allergy med MofA: nasal steroid Indication: allergic/non-allergic rhinitis |
| Triamcinolon |
Class: allergy med MofA: nasal steroid Indication: allergic/non-allergic rhinitis |
| Mometasone |
Class: allergy med MofA: nasal steroid Indication: allergic/non-allergic rhinitis |
| Olopatadine |
Class: Allergy med MofA: antihistamine (H1) Indication: allergic rhinitis |
| Cetirizie |
Class: Allergy med MofA: antihistamine (H1) Indication: allergic rhinitis |
| Risendronate |
Class: Anti-osteoporosis MofA: Bisphosphonate=inhibs osteoclast Indication: Pagets, osteoporosis |
| Ibandronate |
Class: Anti-osteoporosis MofA: Bisphosphonate=inhibs osteoclast Indication: Pagets, osteoporosis |
| Alendronate |
Class: Anti-osteoporosis MofA: Bisphosphonate=inhibs osteoclast Indication: Pagets, osteoporosis |
| Raloxifene |
Class: Anti-osteoporosis MofA: Estrogen receptor modulator--inhibs bone resorption |
| Etonogestrel+Ethinyl Estradiol |
Class: Contraceptives MofA: Suppresses LH and FSH, inhibiting ovulation and altering mucus and endo |
| Ethinyl estradiol+Drospirenone |
Class: Contraceptives MofA: Suppresses LH and FSH, inhibiting ovulation and altering mucus and endo |
| Drospirenone+Ethinyl Estradiol |
Class: Contraceptives MofA: Suppresses LH and FSH, inhibiting ovulation and altering mucus and endo |
| Conjugated Estrogens |
Class: Hormone therapy MofA: binds estrogen receptor, developing and maintaining female chars and reproductive systems Indication: Menopausal sx, vasomotor sx, vulvovaginal atrophy |
| Norgestimate+Ethinyl estradiol |
Clas Oral Contraceptive MofA: suppresses HPA decreasing GnRH release |
| Tadafil |
Class: Men's health MofA inhibs Phosphodiesterase-->enhancing cGMP Indication: Erectile Dysfunction |
| Sildenafil |
Class: Men's health MofA inhibs Phosphodiesterase-->enhancing cGMP Indication: Erectile Dysfunction |
| Tamsulosin |
Class: Adrenergic antagonist MofA: binds alpha-1 receptor, relaxing smooth muscle Indication: BPH |
| Tolterodine |
Class: Anti-Ach (muscarinic) MofA: binds and blocks peripheral AcH receptors (in bladder) Indication: overactive bladder |
Spanish 3
